INTEGRIS Health Woodward Hospital has welcomed Lela Cupp, an advanced practice registered nurse and certified nurse midwife, ...
AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, while Organon overstepped the mark in its promotion of contraceptive Nexplanon ...
Lufkin Women’s Center Obstetrics, Gynecology & Infertility will open its doors Tuesday, Jan. 6, and is now accepting ...
Organon’s latest valuation update nudges its fair value estimate down from $9.67 to $9.36 and edges the discount rate up from 10.20% to 10.25%, a small but telling shift that mirrors Wall Street’s ...
The Organon board of directors has approved the deal. The transaction is expected to close in the first quarter of 2026, subject to required regulatory approvals. “I am incredibly proud of the work ...
Shares of pharmaceutical company Organon (NYSE:OGN) fell 2.9% in the afternoon session after the company lowered its full-year sales guidance and analysts subsequently cut their price targets on the ...
Carrie Cox announced her transition to Executive Chair, taking a more active management role following the Board’s investigation into improper U.S. sales practices for Nexplanon. Cox stated, "The ...
Organon recently completed a leadership transition, appointing Joseph Morrissey as Interim CEO following the resignation of Kevin Ali after an internal investigation into sales practices related to ...
Oct 27 (Reuters) - Organon (OGN.N), opens new tab said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to ...
(RTTNews) - Organon & Co. (OGN), a pharmaceutical company, said on Monday that its Chief Executive Officer Kevin Ali has stepped down after an internal investigation found improper wholesaler sales ...
Organon said its chief executive, Kevin Ali, has stepped down following an internal investigation into sales practices for the company's Nexplanon birth-control implant. The Jersey City, N.J., company ...